1.
The Policy Gist and The Analysis of related Problems about Drafting Reevaiuation for Post-Marketing Drug;
制定我国《药品再评价管理办法》的法律依据及有关问题分析
2.
Study on the Supervision and Re-evaluation Approach to Post-market Medical Products of FDA;
FDA对医药产品上市后监测与再评价的方法及其启示
3.
Statin for Preventing Stroke Recurrence: A Systematic Review
他汀类药物预防卒中再发的系统评价
4.
Drug Pricing Guided by Pharmacoeconomic Evaluation;
利用药物经济学评价指导药品定价的探讨
5.
Application of Pharmacoeconomics Evaluation in Drug Pricing;
药物经济学评价在药品定价中的应用研究
6.
Scheme for Mutual Recognition of Evaluation Reports on Pharmaceutical Products
相互承认医药产品评价报告计划
7.
Quality assessment of 222 ADR reports
222份药品不良反应报告表质量评价
8.
Study on Quality Evaluation on Herbal Drug Culticated by Standard Operation Procedure (Ⅷ);
规范化种植中药材的品质评价研究（Ⅷ）
9.
Study on Methods of Adverse Drug Reaction/Event Reporting Assessment
药品不良反应/事件报告评价方法研究
10.
Evaluation and analysis of group procurement policy of drugs for hospitals in China
医院药品集中采购政策的评价与分析
11.
The Quality Evaluation of Our Adverse Drug Reaction Report Tables
我市药品不良反应报告表的质量评价
12.
Discussion on role of enterprises in re-evaluation of traditional Chinese medicine injection
中药注射剂安全性再评价企业应注意的问题
13.
Discussion on safety and reevaluation of Chinese herbal medicine injection
关于中药注射剂安全性及再评价的探讨
14.
Study on the Retrieval of Adverse Drug Reaction in Prescription to Nonprescription Drugs Switch
处方药转换非处方药评价中有关药品不良反应检索的问题探讨
15.
Improvement and perfect for the model-marketed drug sampling and testing for quality evaluation--preliminary discussion on the drug quality study
药品评价抽验模式的改进和完善——对药品质量状况分析方法的初探
16.
Technique obstacles of using Pharmacoeconomics evaluation to help the drug price making;
在我国药品定价中应用药物经济学评价的技术性障碍分析
17.
Discussion on Drug Reevaluation by Analyzing Adverse Drug Reaction of Traditional Chinese Medicine Injection
从中药注射剂不良反应看中药的上市后再评价问题
18.
The establishment of the inventory management performance value system to evaluate the costly medicine anagement in hospital
建立库存管理绩效评价体系 评价医疗机构贵重药品管理